RT Journal Article
SR Electronic
T1 Central and peripheral nervous system complications of COVID-19: A prospective tertiary center cohort with 3-month follow-up
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.15.20231001
DO 10.1101/2020.11.15.20231001
A1 Vardan Nersesjan
A1 Moshgan Amiri
A1 Anne-Mette Lebech
A1 Casper Roed
A1 Helene Mens
A1 Lene Russel
A1 Lise Fonsmark
A1 Marianne Berntsen
A1 Sigurdur Thor Sigurdsson
A1 Jonathan Carlsen
A1 Annika Langkilde
A1 Pernille Martens
A1 Eva Løbner Lund
A1 Klaus Hansen
A1 Bo Jespersen
A1 Marie Norsker Folke
A1 Per Meden
A1 Anne-Mette Hejl
A1 Christian Wamberg
A1 Michael E. Benros
A1 Daniel Kondziella
YR 2020
UL http://medrxiv.org/content/early/2020/11/17/2020.11.15.20231001.abstract
AB Objective To systematically describe CNS and PNS complications in hospitalized COVID-19 patients.Methods We conducted a prospective, consecutive, observational study of adult patients from a tertiary referral center with confirmed COVID-19. All patients were screened daily for neurological and neuropsychiatric symptoms during admission, at discharge and at 3-month follow-up. We classified complications as caused by SARS-CoV-2 neurotropism, immune-mediated or critical illness-related.Results From April-September 2020, we enrolled 61 consecutively admitted COVID-19 patients, 35 (57%) of whom were referred to ICU for respiratory failure. Evaluation revealed a higher frequency of CNS/PNS symptoms in ICU patients compared to non-ICU patients. The most common CNS complication was encephalopathy (n=22, 36.1%), which was severe in 13 patients (GCS≤12), including 8 with akinetic mutism. Length of ICU admission was an independent predictor of encephalopathy (OR=1.23). Other CNS complications included ischemic stroke, a biopsy-proven acute necrotizing encephalitis, and transverse myelitis. The most common PNS complication was critical illness polyneuromyopathy (13.1%), with prolonged ICU stay as independent predictor (OR=1.14). Treatment-related PNS complications included meralgia paresthetica. Of 41 complications in total, 3 were classified as para/post-infectious. The remainder included cases secondary to critical illness or other causes (n=34) or without sufficient investigations (n=4). Cerebrospinal fluid was negative for SARS-CoV-2 RNA in all 5 patients investigated.Conclusions CNS/PNS complications were common in hospitalized COVID-19 patients, particularly in ICU patients, and often attributable to critical illness. In cases with COVID-19 as the primary cause for neurological disease, there were no signs of viral neurotropism, but laboratory changes suggested autoimmune-mediated mechanisms.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Lundbeck Foundation (R349-2020-658). The sponsor had no role in the acquisition of the data, interpretation of the results or the decision to publish the findings. Conflict of Interest Disclosures: The authors have no relevant financial disclosuresAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethics Committee of the Capital Region of Denmark approved the study and waived the need for written consent because the risks were deemed negligible (reference j.nr. 20025838)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified data can be made available to qualified investigators upon reasonable written request to the corresponding author.